New Zealand markets open in 8 hours 58 minutes

Zhuhai Rundu Pharmaceutical Co., Ltd. (002923.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
11.38+0.15 (+1.34%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.76B
Enterprise value 4.13B
Trailing P/E 66.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.00
Price/book (mrq)3.11
Enterprise value/revenue 3.58
Enterprise value/EBITDA 27.27

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-18.37%
S&P500 52-week change 326.27%
52-week high 314.44
52-week low 36.81
50-day moving average 310.60
200-day moving average 311.98

Share statistics

Avg vol (3-month) 35.03M
Avg vol (10-day) 33.62M
Shares outstanding 5334.89M
Implied shares outstanding 6334.89M
Float 8119.07M
% held by insiders 166.48%
% held by institutions 12.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.35
Forward annual dividend yield 43.12%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 42.27
Payout ratio 4205.88%
Dividend date 3N/A
Ex-dividend date 431 May 2023
Last split factor 21.4:1
Last split date 331 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 4.48%
Operating margin (ttm)11.66%

Management effectiveness

Return on assets (ttm)3.50%
Return on equity (ttm)4.54%

Income statement

Revenue (ttm)1.24B
Revenue per share (ttm)3.74
Quarterly revenue growth (yoy)-14.80%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)55.52M
Diluted EPS (ttm)0.17
Quarterly earnings growth (yoy)-28.10%

Balance sheet

Total cash (mrq)223.36M
Total cash per share (mrq)0.67
Total debt (mrq)593.84M
Total debt/equity (mrq)49.15%
Current ratio (mrq)2.09
Book value per share (mrq)3.61

Cash flow statement

Operating cash flow (ttm)233.6M
Levered free cash flow (ttm)-27.07M